Published on 8 Nov 2022 on Zacks via Yahoo Finance
Precision BioSciences (DTIL) Reports Q3 Loss, Tops Revenue Estimates
Precision BioSciences (DTIL) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 37.14%. A quarter ago, it was expected that this genome editing company would post a loss of $0.43 per share when it actually produced a loss of $0.44, delivering a surprise of -2.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.